New stem cell approach targets functional cure for diabetes - News-Medical
Researchers are advancing a novel cell therapy approach for Type 1 diabetes, focusing on long-term islet cell durability without the need for immunosuppression.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A new stem cell-based approach is undergoing exploration as a potential functional cure for Type 1 diabetes. The method utilizes immune-engineered, hypoimmune-modified islet cell transplantation designed to survive in the body without requiring traditional immunosuppressive drugs.
Coverage from outlets including News-Medical, The Manila Times, and Bioengineer.org emphasizes new research and long-term data regarding the durability of these transplanted cells. A follow-on publication in The New England Journal of Medicine (NEJM) provides the foundation for this reporting, while Longevity.Technology notes that Sana Biotechnology is preparing an update for the upcoming EASD meeting.
Future developments will center on the initial human trial results and the formal presentation of data by Sana Biotechnology at the European Association for the Study of Diabetes (EASD). Specific details regarding patient outcomes in the ongoing trial are not yet available in current reporting.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 35m ago.
Quick answers
What is the core focus of the new diabetes treatment?
The research focuses on using hypoimmune-modified islet cell transplantation to potentially treat Type 1 diabetes.
Is immunosuppression required for this treatment?
Current coverage indicates the approach aims to allow transplantation without the need for immunosuppression.
Where can the technical data on this research be found?
Data regarding the durability of these cells is featured in a publication in The New England Journal of Medicine.
Coverage (5)
- First Human Trial Explores Immune-Engineered Cell Therapy for Type 1 Diabetes Bioengineer.org · 1d ago
- Sana Biotech heads to EASD with diabetes cell therapy update Longevity.Technology · 1d ago
- New Research Seeks to Help Transplanted Cells Thrive in Type 1 Diabetes Treatment Newswise · 1d ago
- Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 D The Manila Times · 1d ago
- New stem cell approach targets functional cure for diabetes News-Medical · 1d ago
Topics
Related trends
Research Shows a Certain Amount of Strength Training Every Week Can Help You Live Longer
New research suggests a correlation between weekly strength training and increased longevity, alongside potential benefits for brain and heart health.
Heat wave warning: Common medications that can increase your risk of heat illness
Medical professionals are issuing warnings regarding how common medications can increase heat-related health risks during high-temperature events.
Derivation of functional retinal endothelial cells from human pluripotent stem cells for therapeutics and modelling
Researchers have successfully derived functional retinal endothelial cells from human pluripotent stem cells, creating new avenues for vision restoration.
Strange Side Effect Found Among Ozempic Users—and It Has to Do With Smell and Taste
Medical reports are highlighting emerging accounts of taste and smell disturbances among users of GLP-1 medications like Ozempic and Mounjaro.
Two patients with severe autoimmune disease remain relapse-free for over 15 years after stem cell transplant
Two patients with severe autoimmune disease have remained free of relapses for over 15 years following a stem cell transplant.
Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS
NHS becomes first in Europe to fund drug that can delay type 1 diabetes by years